Compared with the PR group, patients in the PD group tended to have higher T/N staging and showed a greater proportion of lymphovascular invasion, perineural invasion and KRAS mutation, although these differences did not reach statistical significance.
← all excerpts
Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylation.
1
—
—